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ABSTRACT 
The AlkB family of Fe(II) and -
ketoglutarate dependent dioxygenases is a class of 
ubiquitous direct reversal DNA repair enzymes 
that remove alkyl adducts from nucleobases by 
oxidative dealkylation. The prototypical and 
homonymous family member is an Escherichia coli 
“adaptive response” protein that protects the 
bacterial genome against alkylation damage. AlkB 
has a wide variety of substrates, including 
monoalkyl and exocyclic bridged adducts. Nine 
mammalian AlkB homologs exist (ALKBH1-8, 
FTO), but only a subset functions as DNA/RNA 
repair enzymes. This mini-review presents an 
overview of the AlkB proteins including recent 
data on homologs, structural features, substrate 
specificities, and experimental strategies for 
studying DNA repair by AlkB family proteins.  
 
AlkB is an E. coli Fe(II)/KG-dependent 
dioxygenase that reverses DNA alkylation damage 
E. coli cells exposed to a low dose of a 
methylating agent such as methylnitronitroso-
guanidine (MNNG) upregulate a transcriptional 
program that confers significant resistance to 
subsequent, higher levels of alkylation insult. This 
phenomenon, discovered in 1977 by Samson and 
Cairns was coined the adaptive response (1). At its 
core, the adaptive response relies on the activity of 
four proteins: Ada, AlkA, AlkB and AidB, whose 
overexpression affords the observed bacterial 
resistance to the deleterious effects of alkylating 
agents (1). Three of the four genes (Ada, AlkA and 
AlkB) encode DNA repair proteins that combat the 
mutagenic and toxic effects of alkylated bases. 
Although the biological functions of Ada (a methyl 
transferase) and AlkA (a glycosylase) were 
established relatively quickly, the function of AlkB 
remained mysterious until 2001, when Aravind and 
Koonin, using sequence homology alignments, 
predicted that AlkB is an Fe(II) and α-ketoglutarate 
(αKG)-dependent dioxygenase (2). Soon after, AlkB 
was established as a prototypical oxidative 
dealkylation DNA repair enzyme (3–5) that protects 
the bacterial genome against alkylation damage (6–
10). AlkB uses molecular oxygen to oxidize the alkyl 
groups on alkylation-damaged nucleic acid bases, 
such as 1-methyladenine (m1A), 3-methylcytosine 
(m3C) (7, 8) and 1,N
6
-ethenoadenine (εA) (9, 11); the 
oxidized alkyl groups are subsequently released as 
aldehydes, regenerating the undamaged bases (Fig. 1). 
The decade of research that followed the 2002 
discovery of the enzymatic properties of AlkB (7, 8) 
greatly expanded our understanding of the biological 
functions of the AlkB dioxygenases. This minireview 
summarizes the most salient aspects of this research. 
 
Bacterial homologs of the E. coli AlkB 
The E. coli AlkB protein is by far the best 
studied enzyme in the family. However, AlkB 
homologs exist in most bacteria and almost all 
eukaryotes. Speaking to the remarkable versatility and 
ubiquity of the AlkB proteins, even certain single-
stranded plant-infecting RNA viruses (e.g., 
Flexiviridae (now classified as Alphaflexiviridae, 
Betaflexiviridae, and Gammaflexiviridae)) encode an 
AlkB homolog that can repair alkylated bases in DNA 
and, preferably, RNA (12). 
The majority of aerobic bacterial species 
express AlkB proteins, which show a great diversity 
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of substrate specificity (4, 13, 14). Given the AlkB 
requirement for molecular oxygen, obligate anaerobic 
bacteria (e.g., Clostridium, Bacteroides, 
Bifidobacterium) do not appear to have AlkB type 
proteins (4, 14). A careful bioinformatics analysis of 
the homologous sequences found four phylogenetic 
groups of bacterial AlkB proteins denoted 1A, 1B, 2A 
and 2B (14). Group 1A proteins, which include the E. 
coli AlkB are characterized by robust oxidative 
dealkylation activities and broad substrate 
specificities. Part of this group are the Streptomyces 
AlkB proteins, which share 79% sequence identity 
with the E. coli AlkB and have been shown to repair 
both methylated and etheno lesions (14). Group 1B 
proteins, primarily found in the β and γ subdivisions 
of proteobacteria and in cyanobacteria, also show 
wide substrate preferences. They are the most related 
to the eukaryotic ALKBH2 and ALKBH3 homologs. 
Group 2A proteins, often found in the  
proteobacteria (e.g., Agrobacterium, Rickettsia, 
Rhizobium), share strong homology with the 
ALKBH8 proteins from animals and plants, which 
have been implicated in tRNA posttranscriptional 
modification rather than true DNA or RNA repair. 
Finally, group 2B proteins, often found in soil 
bacteria (e.g., actinobacteria) but also in 
Xanthomonas and Burkholderia, are most likely to 
show substrate specialization; some enzymes have 
high activity on monoalkyl lesion, but no activity on 
bridged adducts (e.g., MT-2B from Mycobacterium 
tuberculosis), whereas others are exactly the opposite 
(e.g., XC-2B from Xanthomonas campestris) (14). 
Such specialization presumably reflects an adaptation 
to a specific environmental stressor. Additionally, 
unlike E. coli, many bacterial genomes contain two or 
even three AlkB family proteins (14). So far, no AlkB 
homologs have been found in Archaea (14). 
 
Eukaryotic and mammalian AlkB homologs 
Most eukaryotic cells have several AlkB 
homologs, with the notable exception of 
Saccharomyces cerevisiae, which lacks this class of 
DNA repair enzymes. Mammalian cells have 9 
homologs (2, 4, 15); the first eight have been denoted 
ALKBH1-8, while the ninth is known as FTO (fat-
mass and obesity-associated) (16). Evolutionarily 
speaking, ALKBH5 and FTO are the newest AlkB 
proteins, being found only in vertebrates (17, 18). The 
other seven AlkB homologs are conserved across all 
metazoans, including worms and fruit flies (13). 
Among the nine human AlkB homologs, 
ALKBH2 (19–25) and ALKBH3 (25–29) are bona 
fide nuclear DNA repair enzymes, being the only 
homologs that can complement the function of E. coli 
AlkB in vivo (25, 30) and protect cells against 
alkylation damage both in cell culture and in animal 
models (22, 28, 30). ALKBH1, featuring the highest 
sequence homology to E. coli AlkB, can function as a 
mitochondrial nucleic acid demethylase (31) but also 
exhibits apyrimidinic/apurinic lyase activity (32–34). 
The lyase activity has also been observed in ABH1, 
the Schizosaccharomyces pombe homolog, which, 
however, has no demethylase activity (35). 
Additionally, ALKBH1 can also demethylate H2A 
histone (36), an activity more consistent with the 
impaired development phenotype of the ALKBH1 
KO mice (37, 38).  
The remaining homologs have no known 
activity on DNA substrates; instead, they demethylate 
RNA or proteins. Both FTO (39–41), whose 
overexpression is closely linked to obesity and 
diabetes (16, 42, 43), and ALKBH5 (44–48) repair 
primarily N6-methyladenine (m6A) in RNA (Fig. 1). 
FTO also repairs 3-methylthymine (m3T) and 3-
methyluracil (m3U) in ssDNA (49). ALKBH8 (50–54) 
is involved in the maturation of tRNA featuring both 
an S-adenosylmethionine-dependent methyl-
transferase domain that methylates 5-carboxy-
methyluridine (cm5U) to 5-methoxycarbonyl-
methyluridine (mcm5U), and a dioxygenase domain 
that hydroxylates mcm5U to generate (S)-5-methoxy-
carbonylhydroxymethyluridine (mchm5U), a 
common functional modification at the wobble 
position of tRNA (51, 52). The main function of 
ALKBH4  seems to be actin demethylation (55, 56). 
ALKBH7, which plays a role in alkylation-induced 
necrosis (57–59), is believed to act on protein 
substrates, but their identity is not currently known. 
Finally, the function and substrates of ALKBH6 
remain to be established. Although also members of 
the Fe(II)/KG dioxygenase superfamily, the 
mammalian TET (ten-eleven translocation) proteins, 
which play an important role in the epigenetic 
reprogramming of the cell (60), are only distantly 
related to the AlkB proteins, and they will be covered 
in other minireviews. 
 
Structural features of the AlkB dioxygenases 
Crystal structures of the E. coli AlkB (61–64), 
and the human homologs ALKBH2 (62), ALKBH3 
(29), ALKBH5 (65), ALKBH7 (59), ALKBH8 (66), 
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and FTO (67) have provided significant insight into 
the molecular mechanism of the oxidative 
dealkylation catalyzed by AlkB dioxygenases. The 
active site of these enzymes is contained on a 
characteristic double-stranded beta helix domain, also 
known as a “jelly-roll” fold, consisting of eight β-
strands arranged in pairs in a helical conformation to 
form the core that binds the Fe(II) and KG cofactors 
using conserved residues (61, 62) (Fig. 2A). The E. 
coli AlkB also contains a unique 90 residue N-
terminal subdomain that interacts with the 
oligonucleotide substrate containing the damaged 
base and covers the active site by forming a 
"nucleotide recognition lid". Being conformationally 
flexible, this lid can accommodate substrates of 
variable sizes, which can explain the diverse substrate 
specificity of the enzyme (see below). However, 
recent data on bacterial AlkB homologs suggest that 
this domain is not the only factor governing the 
substrate specificity (68). The active site of AlkB  
contains a 3 Å-wide oxygen diffusion tunnel from the 
protein surface to the oxygen binding site (61). 
His131, Asp133 and His187 of E. coli AlkB, together 
with molecular oxygen (or water under anaerobic 
conditions) and KG bound in a bidentate fashion, 
form the octahedral primary coordination sphere 
around the non-heme iron (Fig. 2B-D). The KG 
cofactor is held in place through two salt bridge 
interactions between the Arg204, Arg210 and the 
carboxylates of KG (61, 63). The octahedral 
coordination and the global geometry are conserved 
in AlkB complexes in which Fe(II) is replaced with 
Co(II) or Mn(II), but such replacement results in 
closure of the oxygen diffusion tunnel, producing an 
oxygen-resistant phenotype (63). 
 
The mechanism of AlkB-catalyzed dealkylation 
Similar to other non-heme iron dioxygenases, 
the AlkB-catalyzed oxidative dealkylation reaction is 
initiated by the binding of molecular oxygen to Fe(II) 
in the active site by replacing the bound water 
molecule (69–76). Cleavage of molecular oxygen 
generates an Fe(IV)-oxo reactive moiety, while the 
KG ligand is oxidatively decarboxylated to 
succinate. Once CO2 is released from the active site, 
the reactive Fe(IV)-oxo ligand migrates adjacent to 
the target alkyl group on the nucleobase substrate and 
hydroxylates the alkyl moiety (73–76). The resulting 
carbinoliminium is typically unstable and dissociates 
(in a spontaneous or catalyzed fashion) into an 
aldehyde product and the unmodified (repaired) base. 
For simple alkyl substrates, AlkB oxidizes the 
carbon attached to a nucleobase nitrogen atom (i.e., 
ring nitrogen or exocyclic amine). The resulting 
carbinol-iminium species (e.g., 3-hydroxymethyl-
cytosine from m3C (Figure 1), or 1-hydroxy-
methyladenine from m1A) have been experimentally 
observed in AlkB oxidation reactions performed in 
crystallo (64). Specifically, the AlkB-substrate 
complex, together with Fe(II) and KG, is first 
crystalized under anaerobic conditions. The reaction 
is then initiated by exposing the crystals to air (64).  
In the case of etheno lesions (e.g., εA), the 
AlkB dealkylation was proposed to involve the 
oxidation of the etheno bridge to an epoxide, followed 
by hydrolysis of the epoxide to a glycol and 
subsequent release of the dialdehyde glyoxal (Fig. 1) 
(9, 11). The glycol corresponding to εA has been 
experimentally observed in crystallo (64). The 
epoxide formation, however, has been recently 
challenged in a computational study, which suggested 
instead that the AlkB reaction with εA proceeds via a 
zwitterion intermediate (77). Nevertheless, further 
experimental work is needed to establish the identity 
of the reaction intermediate.   
The binding affinity of E. coli AlkB to 
damaged DNA is influenced by both the damaged 
base, and the backbone phosphates of the substrate 
(61). Residues Thr51, Tyr76 and Arg161, conserved 
across all eubacterial AlkB homologs, form extensive 
hydrogen bonding interactions with the backbone 
phosphates (29, 61, 62). In the AlkB repair complex, 
the central alkylated base is splayed out of the DNA 
helix; the stacking interactions between the normal 
flanking bases stabilize the resulting backbone 
conformation. The flipped-out alkylated base is 
sandwiched between AlkB conserved residues Trp69 
and His131, while the DNA backbone is distorted 
such that the bases flanking the flipped damaged base 
stack with each other (62). 
Unlike E. coli AlkB, ALKBH2 promotes the 
flipping of the damaged base by using an aromatic 
finger residue, Phe102, which intercalates into the 
duplex DNA and fills the gap left by the flipped base 
(62). Moreover, while AlkB only interacts with the 
lesion strand, ALKBH2 interacts with both DNA 
strands, which may explain the observed differences 
in substrate preference: ALKBH2 prefers dsDNA, 
while E. coli AlkB prefers ssDNA or RNA (61, 62). 
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Substrate specificity of AlkB dioxygenases 
In addition to the originally reported AlkB 
substrates, m1A and m3C, a wide variety of modified 
bases are substrates for the AlkB family proteins, 
including monoalkylated bases with alkyl moieties of 
various sizes (Table 1) and bases featuring exocyclic 
bridged adducts (Table 2). Additionally, AlkB 
proteins can process both single-stranded and double-
stranded substrates, and in both DNA and RNA. 
 
Monoalkyl DNA lesions 
Recent studies have highlighted that at least 
in vitro, E. coli AlkB is able to repair all seven N-
methyl adducts occurring at the Watson-Crick base 
pairing interface of the four DNA bases, specifically 
m1A, m6A, 1-methylguanine (m1G), N2-
methylguanine (m2G), m3C, N4-methylcytosine 
(m4C), and m3T (Table 1) (78–81). These findings 
emphasize the important role of AlkB (and by 
analogy, the AlkB family enzymes) as a versatile 
preserver of genomic integrity under alkylation stress 
(81). Nevertheless, not all alkylated DNA bases are 
substrates for AlkB repair. N-alkylated 3-
methyladenine (m3A) (25), O-alkylated O6-
methylguanine (80) and C-alkylated 5-methylcytosine 
(m5C) are not processed by AlkB (80). Instead, m3A 
is a substrate for glycosylases, O6mG is repaired by 
O6-methylguanine DNA methyltransferases, and m5C 
is oxidized by the TET enzymes. 
Interestingly, the ability of AlkB to 
demethylate exocyclic DNA adducts such as m4C and 
m6A suggests a potential additional biological 
function for AlkB, besides DNA repair. Often, the 
m4C and m6A modifications are not deleterious, but 
rather physiological post-replicative DNA markers 
that control strand discrimination, replication 
initiation and even gene expression in certain bacteria 
(82, 83). Furthermore, the demonstrated chemical 
competence of E. coli AlkB to oxidize a wide range 
of substrates has anticipated the putative substrate 
specificity of other AlkB homologs (e.g., m6A in 
RNA is now considered the canonical substrate for 
ALKBH5 and FTO), including functional roles 
beyond DNA repair.  
Although most widely appreciated as a 
demethylating enzyme, E. coli AlkB also repairs 
higher order alkyl adducts. Ethylated bases such as 1-
ethyladenine (e1A), N2-ethylguanine (e2G), 3-
ethylcytosine (e3C) and 3-ethylthymine (e3T) are 
known substrates for AlkB family proteins (25, 78, 
81). Among N2-substituted alkylguanines, the bulky 
furfuryl (FF) and tetrahydrofurfuryl (HF) lesions can 
also be removed by E. coli AlkB (81). 
The efficiency with which AlkB enzymes 
process different N-alkyl nucleobases varies 
considerably, depending both on the identity of the 
base and the position of the alkyl group on the base. 
For the E. coli AlkB, m1A is a better substrate than 
m6A (these damaged bases are regio-isomers) (84); 
similarly, m3C is a better substrate than m4C (81). 
When comparing two different bases alkylated at the 
same position, m1A is a better AlkB substrate than 
m1G both in vivo and in vitro (78, 80). Generally, 
alkylated adenines and cytosines are repaired more 
efficiently than alkylated guanines and thymines; 
alkyl groups on the ring nitrogens are removed more 
efficiently than alkyl groups on the exocyclic amines. 
The preference of the AlkB enzymes towards 
m1A and m3C may reflect the fact that these lesions 
are positively charged under physiological pH, which 
is believed to help with the AlkB recognition and 
binding to the damaged bases, and may also allow a 
faster release of formaldehyde from the carbinol-
iminium intermediates (85). Additionally, a 
stabilizing hydrogen bonding interaction exists 
between the AlkB invariant residue Asp135 and the 
6-amino or 4-amino group of adenine or cytosine, 
respectively (61, 63, 85). For neutral lesions, such as 
m1G and m3T that contain hydrogen bond acceptors 
at the equivalent position, the interaction is weaker, 
being mediated through water molecules; this may 
account for the less efficient repair of m1G and m3T 
relative to m1A and m3C.  
One notable peculiar feature of the E. coli 
AlkB is its ability to repair equally well the top two 
substrates, m1A and m3C, despite the large size 
difference between them. Biochemical and structural 
studies have shown that AlkB achieves its diverse 
substrate specificity by tailoring its kcat and KM values 
for various substrates (63). For example AlkB has a 
significantly higher kcat and KM for m3C when 
compared with m1A. Thus, AlkB maintains a similar 
net catalytic activity (kcat/KM) by increasing the 
turnover rate of the substrate with lower affinity. Co-
crystals of AlkB with both substrates suggest a 
correlation between the kcat and KM compensation and 
the atomic packing density in the active site (i.e., the 
extent to which the substrate fills the volume of the 
active site). Smaller substrates such as m3C have a 
lower atomic packing density, which seems to 
promote a faster rate (kcat) at the expense of a weaker 
binding (higher KM) (63). The mechanistic basis for 
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this relationship is not fully understood, but it is 
suspected that the stereochemical properties of the 
substrate directly influence (via quantum-mechanical 
effects) the rate with which the electrons or atoms 
rearrange during the course of the reaction (63). 
 
Monoalkyl RNA lesions 
E. coli AlkB and human ALKBH1 and 
ALKBH3 can oxidize and remove the methyl group 
of m1A, m3C and m1G in RNA substrates (15, 30, 
86). The bacterial AlkB protein XC-1B can also 
repair RNA substrates (14). The ability of these 
proteins to work on RNA correlates with their 
preference to repair ssDNA over dsDNA. Both AlkB 
and ALKBH3 can function as RNA repair enzymes in 
the cell (87). In fact, the primary function of 
ALKBH3 is speculated to be RNA repair, argued by 
its equal activity on RNA and ssDNA and its diffuse 
cellular localization (cytosol and nucleus) (30, 86).  
Other AlkB homologs, such as ALKBH5, 
FTO and ALKBH8 have been shown to work 
exclusively on RNA substrates. Both ALKBH5 and 
FTO remove the methyl group from m6A in RNA 
(Fig. 1) (41, 47). However, these oxidation 
/demethylation reactions likely constitute an 
additional layer of mRNA regulation (ALKBH5 and 
FTO), or post-transcriptional tRNA modification 
(ALKBH8), and thus not true repair mechanisms for 
alkylation-damaged RNA. 
 
Exocyclic bridge containing lesions  
Of all the four possible etheno adducts of 
DNA nucleobases, εA (9, 11, 68), 3,N4-
ethenocytosine (εC) (9, 68) and 1,N2-
ethenoguanine(1,N2-εG) (68, 88) are substrates for 
AlkB dioxygenases, while N2,3-ethenoguanine (N2,3-
εG) is not  (Table 2) (88). While the ability of E. coli 
AlkB to efficiently dealkylate εA and εC both in vitro 
(9, 11) and in vivo (9) in ssDNA was known since 
2005, the AlkB activity on 1,N2-εG was reported only 
recently. Although one study concluded that E. coli 
AlkB does not efficiently process 1,N2-εG in vitro 
(68), a higher resolution MS method  revealed that 
1,N2-εG is a substrate (albeit a modest one) for E. coli 
AlkB both in vitro and in vivo (88). The inability of E. 
coli AlkB to process the remaining etheno lesion, 
N2,3-εG, can be explained structurally; in the active 
site of the protein, the etheno bridge is spatially too 
far away from the iron-oxo center  (Fig. 2C,D) (88).  
The etheno lesions are excellent substrates for 
many members of the AlkB family. The bacterial 
AlkB proteins RE-2A (Rhizobium etli), SA-2B 
(Streptomyces avermitilis) and XC-2B can repair εA, 
εC and 1,N2-εG, both in ssDNA and dsDNA 
substrates (68). In fact, RE-2A and XC-2B are 
specialized AlkB proteins that remove only etheno 
lesions (68), but do not process monoalkyl substrates 
(14). Similarly, the human homolog ALKBH2 
removes all the three etheno lesions in dsDNA, but 
only εA and εC in ssDNA, where the repair is less 
efficient (68). By contrast, some AlkB proteins are 
more specialized. The bacterial proteins SA-1A and 
XC-1B remove only εA and εC, but are inactive on 
1,N2-εG, while SC-1A (Streptomyces coelicolor) 
works only on εA in dsDNA (68). Similarly, the 
human homolog ALKBH3 seems to repair only εC, 
and only in ssDNA (68). Finally, not all AlkB 
proteins can repair etheno adducts; MT-2B and SC-
2B do not process etheno adducts, yet they do repair 
monoalkylated bases (14, 68). 
Other exocyclic bridged lesions can also be 
processed by AlkB dioxygenases (Table 2), but in 
most cases, the substrate is processed initially as a 
monoalkyl lesion. After the initial oxidation, the 
exocyclic bridge can open forming another monoalkyl 
lesion that can either fall apart spontaneously or is 
further oxidized by AlkB. For example, 1,N6-
ethanoadenine (EA), the saturated analog of εA, is 
completely repaired by E. coli AlkB, with the reaction 
involving two successive oxidation steps at the 
carbons on the N1 and N
6
 positions of adenine (84, 
89). Similarly, 3,N4-α-hydroxyethanocytosine (the 
hydrated version of εC), and the three-carbon bridge 
analog 3,N4-α-hydroxypropanocytosine are also good 
AlkB substrates, but require only one oxidation at the 
carbon attached to the N3 of cytosine (10, 85). 
Additionally, three propano- exocyclic lesions of 
guanine ( -hydroxypropanoguanine (HOPG), γ-
hydroxypropanoguanine (γHOPG) and malondialde-
hydeguanine (M1G)) are also processed by E. coli 
AlkB in vitro, but the oxidation steps are thought to 
occur primarily on the open ring forms of the lesions 
(90). 
 
Studying DNA repair by AlkB family dioxygenases 
In vitro strategies 
Most in vitro strategies require expressing 
and purifying the AlkB protein of interest, which is 
then incubated directly with single- or double-
stranded substrates, typically DNA or RNA 
oligonucleotides containing chemically defined 
modified bases (lesions). Phosphoramidites for many 
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common modified bases are commercially available, 
which allows for a straightforward preparation of 
AlkB substrates by using a DNA/RNA synthesizer. A 
careful purification and characterization (by LC-MS) 
of such oligonucleotide substrates are essential, 
because the modified bases are often unstable. 
Two general methods are commonly used to 
analyze the outcome of AlkB reactions. The most 
sensitive method relies on high resolution MS to 
identify the reaction products and intermediates by 
their specific masses. Because this method may detect 
relatively stable reaction intermediates, it often 
provides insight into the mechanism of more complex 
AlkB reactions (84, 90). The main caveats of this 
method are the low throughput (each reaction needs a 
dedicated HPLC-MS run) and the cost (MS 
equipment is expensive). The second method can be 
utilized when the lesion under analysis is either a 
block for a methylation-sensitive restriction enzyme 
(e.g., DpnII), or a good substrate for a glycosylase. 
After the AlkB reaction, the glycosylase would 
generate an abasic site if the lesion is still present, but 
would leave the DNA intact if the canonical base has 
been restored by direct reversal (68). Following 
chemical or enzymatic cleavage at the abasic site, a 
simple PAGE experiment would distinguish between 
the repaired (uncut) and unrepaired (cut) 
oligonucleotides (68). When using a modification-
sensitive restriction enzyme, which only cuts a 
canonical sequence, the digested product (cut) would 
signify repair, while the undigested product (uncut) is 
unrepaired (14). The key advantage of these 
approaches is speed; the efficiency of repair of one or 
more lesions with an entire panel of purified AlkB 
enzymes can be analyzed in one run, in parallel (14, 
68). The caveat of the method is the requirement of an 
efficient and specific glycosylase for every lesion 
studied, or a suitable restriction endonuclease that is 
inhibited by the studied lesion. Additionally, this 
method detects only the fully repaired canonical base 
product of the AlkB reaction, and thus, provides no 
information regarding the reaction intermediates. 
 
In vivo strategies  
Genetic strategies have been used to establish 
the importance of AlkB in protecting cells against 
alkylation damage, long before the Fe(II)/KG-
dependent mechanism was known (6). Later, such 
genetic approaches were combined with biochemical 
tools to evaluate the repair efficiency of AlkB on 
many chemically defined DNA lesions. Specifically, 
an M13 single stranded viral vector is engineered to 
contain site-specifically a modified base and allowed 
to replicate in isogenic AlkB+ and AlkB- cell lines. 
Two metrics are calculated by analyzing the resulting 
viral progeny: 1) lesion bypass – the ability of the 
lesion to block viral replication, as compared to a 
normal base, evaluated with the CRAB assay (91); 2) 
mutagenesis – the ability of the lesion to generate 
mutations at that site, evaluated with the REAP assay 
(78, 91). Any significant positive change in these 
metrics between the AlkB- and AlkB+ strains (i.e., 
improvement in bypass, or decrease in mutagenesis) 
indicates that AlkB contributes to the repair of the 
studied lesion. Compared to the in vitro strategies, 
this method allows evaluation of the AlkB repair 
efficiency in a cellular context, where both the 
enzyme and putative substrates are present at 
physiologically relevant concentrations. As a caveat, 
this approach will not work if the lesion studied does 
not produce a phenotype measurable by the two 
metrics above. For example, m2G is neither a block to 
replication, nor mutagenic; therefore the ability of 
AlkB to repair this lesion in vivo cannot be discerned 
with this method (92). So far, the in vivo genetics 
strategy has been successfully used in E. coli cells to 
establish that m1A, m3C, e3C, m1G, m3T (78), εA, 
εC (9), EA (89) and 1,N2-εG (88) are substrates for 
AlkB repair in vivo, while at the same time 
establishing that N2,3-εG is not an AlkB substrate (88). 
 
Future directions and perspective 
As the body of knowledge regarding the 
specific cellular functions of the AlkB family 
dioxygenases expands, and the complete list of 
substrates for each enzyme, particularly for the 
human homologs becomes known, the field will be 
poised to explore in more depth the regulation of 
AlkB proteins. From the point of view of DNA repair, 
two directions merit attention. First, as gatekeepers of 
genomic integrity, certain AlkB homologs may 
function as tumor suppressor genes (93). When their 
activity is impaired, excessive alkylation DNA 
damage may accumulate, which can lead to mutations 
and malignant transformation or cell death (94, 95). 
Understanding the biochemical mechanisms by which 
AlkB enzymes are rendered inoperative may help 
connect environmental or endogenous factors to 
mutagenesis and cancer. Molecules that compete for 
binding with KG (e.g., the oncometabolite 2-
hydroxyglutarate) or metal ions that compete with the 
required Fe(II) (e.g., Ni(II)) have already been shown 
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to inhibit the activity of certain Fe(II)/KG-
dependent dioxygenases (96, 97). However, the 
relevance of these mechanisms of inhibition to the 
AlkB family of enzymes has not been fully evaluated.  
Second, from an opposite perspective, AlkB 
family proteins may also be key factors that help 
tumor cells withstand chemotherapy and promote 
tumor cell growth (24, 26, 27). Here, the development 
of potent and specific inhibitors of Fe(II)/KG-
dependent dioxygenases becomes an important 
challenge (98, 99). By using the structural and 
mechanistic information available, the development 
of anti-cancer agents or adjuvants that target AlkB 
homologs is certainly within reach. 
The last decade of research on the AlkB 
family dioxygenases has been filled with unexpected 
findings that have propelled the field in leaps and 
bounds. One can only wonder about the still-to-be-
discovered surprises this family of enzymes has to 
offer for the decades to come.  
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Table 1. Chemical structures of the monoalkyl substrates processed by AlkB dioxygenases. The 
repair target within each base is highlighted in red. The lesion phenotype in AlkB-deficient E. coli cells is 
provided in terms of % relative bypass (RB) and % mutagenesis, as determined by the CRAB and REAP 
assays. Bypass efficiencies are reported as a percentage relative to the unmodified DNA base at the lesion 
site.  
 
Alkylated 
base 
Structure Lesion phenotype in vivo  
(AlkB-deficient cells) 
AlkB family dioxygenase that can 
process the lesion 
m1A 
 
 
 Strong replication block 
(13% RB)a (78) 
 Not mutagenic (<1%)b (78) 
DNA: AlkBc, ALKBH2, ALKBH3, XC-
1B, MT-2B 
 
RNA: AlkB, ALKBH1, ALKBH3, XC-
1B 
m3C 
  Strong replication block 
(12% RB) (78) 
 Mutagenic (32%) (78) 
DNA: AlkB, ALKBH2, ALKBH3, MT-
2B, RE-2A, SA-1A, SA-2B, SC-
1A, SC-2B, XC-1B 
RNA: AlkB, ALKBH1, ALKBH3 
m1G 
  Very strong replication 
block (2% RB) (78) 
 Very mutagenic (80%) (78) 
DNA: AlkB 
 
RNA: AlkB, ALKBH1, ALKBH3 
m3T 
  Very strong replication 
block (4% RB) (78) 
 Very mutagenic (59%) (78) 
DNA: AlkB, ALKBH2, ALKBH3 
 
RNA: FTO 
m6A 
  Not a replication blockd 
 Not mutagenicd 
DNA: AlkB 
 
RNA: ALKBH5, FTO 
m4C 
  Not a replication blocke 
 Not mutagenice 
DNA: AlkB 
m2G 
e2G 
  Not a replication block 
(>90% RB) (92) 
 Not mutagenic (<2%) (92) 
DNA: AlkB 
FF 
HF 
  Strong replication blocks 
(<20% RB) in the absence 
of Pol IV (92) 
 Not mutagenic (92) 
DNA: AlkB 
aVery strong replication block (RB<10%), strong replication block (RB 10-50%), mild replication block (RB 50-
90%), not a replication block (RB>90%). 
bNot mutagenic (<2%), slightly mutagenic (2-10%), mutagenic (10-50%), very mutagenic (>50%) 
Repair of DNA alkylation damage by AlkB family dioxygenases 
16 
 
cAlkB notation refers to the E.coli protein. 
dNidhi Shrivastav personal communication. 
eBogdan I. Fedeles personal communication.   
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Table 2. Chemical structures of the exocyclic bridged substrates of AlkB dioxygenases. The repair 
target within each base is highlighted in red. The lesion phenotype in AlkB-deficient E. coli cells is 
provided in terms of % relative bypass (RB) and % mutagenesis, as determined by the CRAB and REAP 
assays. Bypass efficiencies are reported as a percentage relative to the unmodified DNA base at the lesion 
site. All lesions are in DNA. 
 
Alkylated 
base 
Structure Lesion phenotype in vivo  
(AlkB-deficient cells) 
AlkB family dioxygenase that can 
process the lesion 
εA 
 
 
 Very strong replication 
block (6% RB)a (9) 
 Mutagenic (35%)b (9) 
AlkBc, ALKBH2, RE-2A, SA-1A ,SA-
2B, SC-1A, XC-1B, XC-2B,  
 
 
εC 
  Strong replication block 
(15% RB) (9) 
 Very mutagenic (82%) (9) 
AlkB, ALKBH2, ALKBH3, RE-2A, 
SA-1A, SA-2B, SC-2B (ds only), XC-
1B, XC-2B 
 
 
1,N2-εG 
  Very strong replication 
block (2% RB) (88) 
 Mutagenic (35%) (88) 
AlkB, ALKBH2 (ds only), RE-2A (ds 
only), SA-2B, XC-2B 
 
N2,3-εG 
  Strong replication block 
(28% RB) (88) 
 Mutagenic (32%) (88) 
Not believed to be a substrate for the 
AlkB family enzymes. Included for 
comparison only. 
EA 
  Strong replication block 
(14% RB) (89) 
 Slightly mutagenic (4%) 
(89) 
AlkB 
 
 
γHOPG 
  Not a replication block 
(>90% RB)d 
 Slightly mutagenic (7%)d 
AlkB 
HOPG 
  Very strong replication 
block (1% RB)d 
 Very mutagenic (80%)d 
AlkB 
M1G 
   Strong replication block 
(35% RB)d 
 Mutagenic (11%)d 
AlkB 
aVery strong replication block (RB<10%), strong replication block (RB 10-50%), mild replication block (RB 50-
90%), not a replication block (RB>90%). 
bNot mutagenic (<2%), slightly mutagenic (2-10%), mutagenic (10-50%), very mutagenic (>50%) 
cAlkB notation refers to the E.coli protein. 
dJames C. Delaney personal communication. 
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FIGURES & FIGURE LEGENDS 
 
 
 
Figure 1. Examples of oxidative dealkylation reactions (m3C, εA and m6A) catalyzed by AlkB 
family dioxygenases and their proposed mechanisms. HO-m3C is 3-hydroxymethylcytosine, and HO-
m6A is N6-hydroxymethyladenine. 
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Figure 2. Structural aspects of E. coli AlkB protein. A. Crystal structure (PDB 3O1P) of E. coli AlkB, 
featuring the jelly-roll fold, with the m1A substrate flipped out of the DNA duplex into the active site of 
the enzyme. The orange sphere denotes the position of the central metal ion (here Mn(II)) B. Active site 
of E. coli AlkB showing the octahedral coordination around the central metal ion and the relative position 
of the substrates m1A and εA, shown overlaid. The red sphere denotes a water molecule crystalized at the 
molecular oxygen binding site.  C. D. The ethenoguanine lesions 1,N2-εG and N2,3-εG modeled in the E. 
coli AlkB active site (PDB 3O1P) showing the distances between the iron-oxo moiety (red sphere of the 
left side of each central Fe(II)) and the exocyclic bridge carbons). (Reproduced with permission from 
Chang et al., 2015). 
 
